With the continuing increase in standard of living, the focus on quality of life has amplified in recent times. In particular, obesity is a health issue featured in the mass media that has been warranting more attention than ever before. More and more people are coming to realize that obesity is at the root of all habitual illnesses, and because of this correlation interest in obesity treatment is on the rise. Biospace’s body composition analyzer, InBody stands at the center of this anti-obesity movement. With the unparalleled performance of the InBody in the domestic obesity diagnosis market Biospace has solidified its foundation as a professional medical device manufacturer. The plan for the future entails the company’s ongoing development and expansion into a comprehensive professional health care organization. In particular, the company is striving to achieve superior competitiveness that will facilitate success in advanced markets around the world, such as those in the United States, Japan, and Europe.